» Articles » PMID: 3322360

Risk Factors for Acute Graft-versus-host Disease

Overview
Journal Br J Haematol
Specialty Hematology
Date 1987 Dec 1
PMID 3322360
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

Acute graft-versus-host disease (GvHD) is an important complication of bone marrow transplantation in humans. Risk factors are imprecisely defined and controversial. We analysed data from 2036 recipients of HLA-identical sibling transplants for leukaemia or aplastic anaemia to identify risk factors for GvHD. Analyses indicate that grading of GvHD can be reproducibly divided into absent or mild versus moderate to severe; 2-year actuarial probability was 54% (95% confidence interval 52-56%) for absent or mild and 46% (44-48%) for moderate to severe. Factors predictive of development of moderate to severe GvHD include donor/recipient sex-match (female----male greater than others, relative risk 2.0, P less than 0.001). This risk was markedly increased if female donors for male recipients were previously pregnant or transfused (relative risk 2.9, P less than 0.0001). Older patients were at increased risk of GvHD (relative risk 1.6, P less than 0.001), but the age gradient was modest, even the youngest patients had a substantial risk of GvHD and, if parous or transfused female----male transplants were excluded, age was not a significant risk factor. Cyclosporine or methotrexate were equally effective at preventing GvHD and were superior to no prophylaxis (relative risk 2.3, P less than 0.01). These data should be useful in estimating the risk of acute GvHD in an individual patient and in designing clinical trials to investigate methods to modify or prevent GvHD.

Citing Articles

Better clinical outcomes and lower triggering of inflammatory cytokines for allogeneic hematopoietic cell transplant recipients treated in home care versus hospital isolation - the Karolinska experience.

Ringden O, Svahn B, Moll G, Sadeghi B Front Immunol. 2024; 15:1384137.

PMID: 39170616 PMC: 11335608. DOI: 10.3389/fimmu.2024.1384137.


Determining the predictive impact of donor parity on the outcomes of human leukocyte antigen matched hematopoietic stem cell transplants: a retrospective, single-center study.

Azari M, Barkhordar M, Bahri T, Rad S, Kamranzadeh Fumani H, Mousavi S Front Oncol. 2024; 14:1339605.

PMID: 38454927 PMC: 10918844. DOI: 10.3389/fonc.2024.1339605.


Understanding and treatment of cutaneous graft-versus-host-disease.

Hong J, Fraebel J, Yang Y, Tkacyk E, Kitko C, Kim T Bone Marrow Transplant. 2023; 58(12):1298-1313.

PMID: 37730800 PMC: 11759061. DOI: 10.1038/s41409-023-02109-x.


Acute graft-versus-host disease.

Malard F, Holler E, Sandmaier B, Huang H, Mohty M Nat Rev Dis Primers. 2023; 9(1):27.

PMID: 37291149 DOI: 10.1038/s41572-023-00438-1.


Graft versus host disease after liver transplantation: A case report.

Acar S, Arat M, Tecimer T, Polat K, Akyildiz M Hepatol Forum. 2022; 3(1):30-32.

PMID: 35782373 PMC: 9138908. DOI: 10.14744/hf.2021.2021.0006.